No Data
Express News | Kontafarma China Holdings FY Basic EPS HKD -0.0135
KONTA CHINA: ANNOUNCEMENT OF AUDITED RESULTS FOR THE YEAR ENDED 31 DECEMBER 2024
KONTA CHINA (01312.HK) will hold a Board of Directors meeting on March 28 to approve the annual performance.
Gelonghui March 17丨KONTA CHINA (01312.HK) announced that the company will hold a Board of Directors meeting on March 28, 2025, to approve the announcement of the annual performance for the year ending December 31, 2024, as well as to consider the proposal for the distribution of a final dividend (if any).
Express News | Kontafarma China - Expects CONSOL Net Loss of HK$79.2 Mln to HK$118.8 Mln for FY
What does AI pharmaceuticals still lack before a market explosion? | Focus
① From the discovery of targets to the identification of preclinical candidate compounds, current generative AI mainly focuses on the early stages of drug development, which can lead to significant acceleration; ② If AI in drug development is to further expand the realm of possibilities, it must explore more profitable real-world applications.
Kontafarma China Holdings Limited's (HKG:1312) Price Is Right But Growth Is Lacking After Shares Rocket 30%
